565 related articles for article (PubMed ID: 24187453)
1. Clinical applications of next-generation sequencing in colorectal cancers.
Kim TM; Lee SH; Chung YJ
World J Gastroenterol; 2013 Oct; 19(40):6784-93. PubMed ID: 24187453
[TBL] [Abstract][Full Text] [Related]
2. A Genomic Analysis Workflow for Colorectal Cancer Precision Oncology.
Corti G; Bartolini A; Crisafulli G; Novara L; Rospo G; Montone M; Negrino C; Mussolin B; Buscarino M; Isella C; Barault L; Siravegna G; Siena S; Marsoni S; Di Nicolantonio F; Medico E; Bardelli A
Clin Colorectal Cancer; 2019 Jun; 18(2):91-101.e3. PubMed ID: 30981604
[TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing in the clinic: promises and challenges.
Xuan J; Yu Y; Qing T; Guo L; Shi L
Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106
[TBL] [Abstract][Full Text] [Related]
4. Molecular methods for colorectal cancer screening: Progress with next-generation sequencing evolution.
Abbes S; Baldi S; Sellami H; Amedei A; Keskes L
World J Gastrointest Oncol; 2023 Mar; 15(3):425-442. PubMed ID: 37009313
[TBL] [Abstract][Full Text] [Related]
5. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
6. Next-generation biobanking of metastases to enable multidimensional molecular profiling in personalized medicine.
Diaz Z; Aguilar-Mahecha A; Paquet ER; Basik M; Orain M; Camlioglu E; Constantin A; Benlimame N; Bachvarov D; Jannot G; Simard MJ; Chabot B; Gologan A; Klinck R; Gagnon-Kugler T; Lespérance B; Samson B; Kavan P; Alcindor T; Dalfen R; Lan C; Chabot C; Buchanan M; Przybytkowski E; Qureshi S; Rousseau C; Spatz A; Têtu B; Batist G
Mod Pathol; 2013 Nov; 26(11):1413-24. PubMed ID: 23743930
[TBL] [Abstract][Full Text] [Related]
7. Should next-generation sequencing testing be routinely used in metastatic colorectal cancer?
Dienstmann R; Ciner A; Hochster HS
Lancet Oncol; 2018 Nov; 19(11):1434-1435. PubMed ID: 30507475
[No Abstract] [Full Text] [Related]
8. Targeted next generation sequencing of MLH1-deficient, MLH1 promoter hypermethylated, and BRAF/RAS-wild-type colorectal adenocarcinomas is effective in detecting tumors with actionable oncogenic gene fusions.
Vaňková B; Vaněček T; Ptáková N; Hájková V; Dušek M; Michal M; Švajdler P; Daum O; Daumová M; Michal M; Mezencev R; Švajdler M
Genes Chromosomes Cancer; 2020 Oct; 59(10):562-568. PubMed ID: 32427409
[TBL] [Abstract][Full Text] [Related]
9. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
10. Analyzing the cancer methylome through targeted bisulfite sequencing.
Lee EJ; Luo J; Wilson JM; Shi H
Cancer Lett; 2013 Nov; 340(2):171-8. PubMed ID: 23200671
[TBL] [Abstract][Full Text] [Related]
11. Genomic landscape of colorectal cancer in Japan: clinical implications of comprehensive genomic sequencing for precision medicine.
Nagahashi M; Wakai T; Shimada Y; Ichikawa H; Kameyama H; Kobayashi T; Sakata J; Yagi R; Sato N; Kitagawa Y; Uetake H; Yoshida K; Oki E; Kudo SE; Izutsu H; Kodama K; Nakada M; Tse J; Russell M; Heyer J; Powers W; Sun R; Ring JE; Takabe K; Protopopov A; Ling Y; Okuda S; Lyle S
Genome Med; 2016 Dec; 8(1):136. PubMed ID: 28007036
[TBL] [Abstract][Full Text] [Related]
12. Genomic characterization of esophageal squamous cell carcinoma: Insights from next-generation sequencing.
Sasaki Y; Tamura M; Koyama R; Nakagaki T; Adachi Y; Tokino T
World J Gastroenterol; 2016 Feb; 22(7):2284-93. PubMed ID: 26900290
[TBL] [Abstract][Full Text] [Related]
13. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
[TBL] [Abstract][Full Text] [Related]
14. Systemic Therapy for Metastatic Colorectal Cancer: From Current Standards to Future Molecular Targeted Approaches.
Atreya CE; Yaeger R; Chu E
Am Soc Clin Oncol Educ Book; 2017; 37():246-256. PubMed ID: 28561718
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.
Furtado LV; Samowitz WS
Virchows Arch; 2017 Aug; 471(2):235-242. PubMed ID: 28551725
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer: from prevention to personalized medicine.
Binefa G; Rodríguez-Moranta F; Teule A; Medina-Hayas M
World J Gastroenterol; 2014 Jun; 20(22):6786-808. PubMed ID: 24944469
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
Coppedè F; Lopomo A; Spisni R; Migliore L
World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
[TBL] [Abstract][Full Text] [Related]
18. Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.
Patel LR; Nykter M; Chen K; Zhang W
Cancer Lett; 2013 Nov; 340(2):152-60. PubMed ID: 23111104
[TBL] [Abstract][Full Text] [Related]
19. Next-Generation Sequencing Reveals Pathway Activations and New Routes to Targeted Therapies in Cutaneous Metastatic Melanoma.
Carlson JA; Caldeira Xavier JC; Tarasen A; Sheehan CE; Otto G; Miller VA; Stephens PJ; Elvin JA; Vergilio JA; Suh J; Gay LM; Ross JS
Am J Dermatopathol; 2017 Jan; 39(1):1-13. PubMed ID: 28045747
[TBL] [Abstract][Full Text] [Related]
20. Identifying molecular drivers of gastric cancer through next-generation sequencing.
Liang H; Kim YH
Cancer Lett; 2013 Nov; 340(2):241-6. PubMed ID: 23178814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]